Subscribe free to our newsletters via your
. Space Travel News .

AIDS science at 30: 'Cure' now part of lexicon
by Staff Writers
Paris (AFP) May 18, 2013

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

Scientists will pay tribute to the astonishing success of AIDS drugs and highlight steps being taken towards a cure -- a goal once deemed all but out of reach.

Entitled "Imagine the Future," the three-day conference builds on the 30th anniversary on Monday of the isolation of the human immunodeficiency virus (HIV).

The Nobel-winning achievement, by a team led by Luc Montagnier of France's Pasteur Institute, unmasked a killer.

Then began the drive to treat the disease and halt its spread.

"The discovery of HIV in 1983 and the proof that it was the cause of AIDS in 1984 were the first major scientific breakthroughs that provided a specific target for blood-screening tests and opened the doorway to the development of antiretroviral medications," said Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID).

Introduced in 1996, after many years of frantic drug research, antiretrovirals are saving the lives of millions of people infected with HIV and helping to contain the virus' spread, Fauci said in an email.

By suppressing viral levels, antiretrovirals can prevent HIV being transmitted by pregnant women to their unborn children, and by infected people to their sexual partners.

But there have also been setbacks, particularly in the quest for a vaccine.

Only last month, US authorities halted the latest clinical trial -- launched in 2009 -- after the prototype formula failed to prevent infection.

Finding antibodies that are able to identify the slippery, mutating virus has proven to be almost as hard as the proverbial search for a needle in a haystack.

"Vaccine research continues to suffer from setbacks -- but pursue a vaccine we must if we are to truly see the end of AIDS," said Adeeba Kamarulzaman, a professor of infectious diseases at the University of Malaya, who will co-chair a global conference on AIDS science in Kuala Lumpur in June.

Counter-intuitively, the main hope nowadays seems to rest on a cure.

Three years ago, Francoise Barre-Sinoussi -- a 2008 Nobel co-recipient with Montagnier -- mapped a strategy for attacking HIV's "reservoir."

This is the cellular bolthole where the virus lurks after being pounded with antiretrovirals. Once the drugs are stopped, the virus re-emerges and spreads once more through the bloodstream.

"The great challenge will be to fully understand where the virus hides, how it manages to stay hidden so effectively and how to lure it out of its hiding place. We've learnt a lot about this in the past few years," said Sharon Lewin, a professor at Monash University in Melbourne, Australia.

-- 'Functional cure' --

Lewin is part of a team cautiously experimenting with an anti-cancer drug to flush out the virus that destroys the immune system and exposes infected people to pneumonia, TB, and other opportunistic diseases.

In trials on 20 patients, the cancer drug awoke the dormant virus in 90 percent of volunteers. The ultimate goal is to kill the newly-exposed virus, leaving the cell it hid in to die eventually of old age.

"We do have drugs that seem to wake up the virus but these are only the first steps in ultimately clearing it out completely," said Lewin.

Two other small studies using antiretrovirals at a very early stage of infection, before viral levels build up, have excited hopes of a "functional cure."

One involved a baby in Mississippi, apparently cleared of the virus after being given aggressive antiretroviral treatment within 30 hours of birth.

"It is certainly a very exciting finding, but this is only a single case and additional studies are needed to determine whether the circumstances of this particular case can be replicated among other HIV-exposed children," said Fauci.

The other is a small French study of 14 HIV patients, known as the VISCONTI cohort, given drugs very soon -- within 10 weeks -- after infection. Treatment normally starts only once the immune system becomes compromised, sometimes years after infection.

The VISCONTI group stopped taking the daily drugs after about three years, and have remained healthy.

And crucially, none of the individuals are among that rare group of people -- fewer than one percent of the population -- who seem able to naturally stave off HIV and are known as "natural" or "elite controllers."

AIDS has killed 30 million people.

An estimated 34 million people are infected with HIV worldwide, and about 1.8 million die every year.

A year after the Montagnier team's historic publication in Science on May 20, 1983, a team led by Robert Gallo of the United States published similar findings -- triggering an acrimonious debate with research funding and prestige at stake.

It turned out that Gallo had worked on a viral sample originally sent to him by Montagnier.

Credit for isolating HIV thus went to the French team, but Gallo was recognised for determining that the virus caused AIDS, something the Montagnier study was not clear on.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks DiggDigg RedditReddit GoogleGoogle

Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News

H1N1 discovered in marine mammals
Davis CA (SPX) May 17, 2013
Scientists at the University of California, Davis, detected the H1N1 (2009) virus in free-ranging northern elephant seals off the central California coast a year after the human pandemic began, according to a study published May 15, in the journal PLOS ONE. It is the first report of that flu strain in any marine mammal. "We thought we might find influenza viruses, which have been found bef ... read more

O3b Networks' initial satellite is fueled for Arianespace's upcoming Soyuz launch from the Spaceport

Ariane Flight VA214's launch vehicle marks a preparation milestone

ILS Proton Successfully Launches EUTELSAT 3D for Eutelsat

Russia's Proton-M Spacecraft Set to Orbit French Satellite

Nine-Year-Old Mars Rover Passes 40-Year-Old Record

NASA Probe Counts Space Rock Impacts on Mars

Living and Dying on Mars

NASA Curiosity Rover Team Selects Second Drilling Target on Mars

Bright Explosion on the Moon

NASA says meteor impact on the moon glowed like a star

Where on Earth did the moon's water come from

Water on moon, Earth have a common source

'Vulcan' wins Pluto moon name vote

Public to vote on names for Pluto moons

The PI's Perspective: The Seven-Year Itch

New Horizons Gets a New Year's Workout

Critical Kepler Reaction Wheel Fails: Mission End In Sight

Sifting Through the Atmosphere's of Far-Off Worlds

New Method of Finding Planets Scores its First Discovery

Team Takes Part in Discovering New Planet

A-1 Test Stand Houses First Full Engine in Nearly a Decade

Space tourism won't hurt environment: Branson

Boeing X-51A WaveRider Sets Record with Successful Fourth Flight

AFOSR-funded research key to revolutionary 'green' spacecraft propellant

China launches communications satellite

On Course for Shenzhou 10

Yuanwang III, VI depart for space-tracking missions

Shenzhou's Shadow Crew

Asteroid 1998 QE2 To Sail Past Earth Nine Times Larger Than Cruise Ship

NASA's Asteroid Sample Return Mission Moves into Development

Dawn On Route From Vesta to Ceres

Nine-Year-Old Names Target of UA-led NASA Mission

The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement